Diabetes, Heart and Cardiovascular Diseases News Chronicle.  Diabetes, Cardiovascular and Heart Diseases
 Article 335
    Published on July 10, 2018

High fT3 and low fT4 thyroid hormone level in early pregnancy linked to gestational diabetes

Abnormalities in the functioning of the thyroid gland are common in pregnant women and it is associated with labor or delivery complications such as preterm or premature birth, miscarriage and adverse health outcomes (such as hypoglycemia in both newborn child and the mother).

Earlier studies show a limited association between the functioning of the thyroid and the associated risk of gestational diabetes. Some studies have shown the risk of gestational diabetes with thyroid abnormalities such as isolated hypothyroxinemia.

Between 2 to 10 percent of pregnancies in the United States are linked to the development of gestational diabetes (a common metabolic pregnancy complication) due to the high thyroid hormone levels.

A longitudinal study on women early in pregnancy suggest a direct association between risk of gestational diabetes and free triiodothyronine (fT3) levels and the ratio of free triiodothyronine (fT3) and free thyroxine (fT4 or FTI). The study also shows these risks are independent of other risk factors for the development of gestational diabetes.

Researchers have conducted studies on 107 women with gestational diabetes and 214 women without gestational diabetes, aged between 18 and 40 years. They used the Fetal Growth Studies-Singleton cohort data for the study purpose. Researchers have conducted separate analytical studies during the first and second trimesters for risk of development of gestational diabetes. They measured following thyroid markers at four pregnancy visits during their first and second trimester.

  • Free triiodothyronine (fT3)
  • Free thyroxine (fT4 or FTI)
  • Thyroid-stimulating hormone (TSH)

They calculated the fT3:fT4 ratio and determined the gestational diabetes status from their medical record. They accounted thyroid autoimmunity (TAI) status (linked to genetic background and gender) and major gestational diabetes risk factors such as ethnicity, age, and body mass index (BMI) prior to pregnancy in the study results.

The study has found an increased risk of gestational diabetes with the thyroid abnormalities during the first half of pregnancy. The study results show the following thyroid hormone levels during the first and second trimester assessments prior to the diagnosis of gestational diabetes.

  • A significant higher the median fT3 levels and the fT3:fT4 ratio.
  • A significant lower levels of median fT4 (or FTI) levels.

In gestational diabetes risk calculation during the second trimester, researchers have found a 14-fold increased risk of gestational diabetes among the women with the highest fT3:fT4 quartile ratio when compared to the lowest fT3:fT4 quartile ratio. The study has found an association between fT3:fT4 ratio and gestational diabetes development even in the first trimester.

The study also shows a direct association between fT3 and the development of gestational diabetes during the first and second trimester. But there was no relationship between the free thyroxine (fT4) and thyroid-stimulating hormone (TSH) and the development of gestational diabetes.

Researchers think increased conversion of free thyroxine (fT4) to T3 increases free triiodothyronine (fT3) levels and causes gestational diabetes in pregnant women.

This was the first study providing longitudinal data on the association between the markers used to asses thyroid functioning (and fT3:fT4 ratio) and gestational diabetes development. Researchers suggest thyroid screening during early to mid pregnancy period to prevent adverse pregnancy outcomes. There are plans to conduct an analytical study on the effects of these hormones in the fetal growth and outcomes. There is a need to conduct another population study before coming to clinical practice guidelines and recommendations.

This study was supported by the Eunice Kennedy Shriver National Institute of Child Health and the Human Development (NICHD) and the American Recovery and Reinvestment Act of 2009 (ARRA, sometimes called the "Recovery Act").

A study shows the risk of gestational diabetes with fT3 and fT4 thyroid hormone levels.

Senior author of the study was Dr. Cuilin Zhang, MD, MPH, Ph.D., Senior Investigator, the National Institutes of Health (NIH). The study findings were published June 7, 2018 in the Journal of Clinical Endocrinology & Metabolism. Title of the article was "A Longitudinal Study of Thyroid Markers Across Pregnancy and the Risk of Gestational Diabetes." DOI: doi.org/10.1210/jc.2017-02442

Facebook     Google Plus     Twitter
If you like this article, please share it with a friend! Article address is (copy and paste the code below) :

Articles similar to this topic

1. About Gestational Diabetes Mellitus (GDM)
2. Link Between Gestational Diabetes And Depression
3. Weight gain between pregnancies linked to the development of gestational diabetes
4. Green Tea EGCG Compound Found To Improve Gestational Diabetes GD Health Outcomes
5. Increase In Risk Of Gestational Diabetes With Increase In Outdoor Temperatures
6. Risk Of Gestational Diabetes With Weight Gain Leading To Pregnancy
7. New Blood Glycated Protein CD59 Or GCD59 Test To Diagnose Gestational Diabetes Early
8. Increased risk of hypothyroidism in type 2 diabetes patients
9. Early Menstrual Periods Is A Risk Of The Development Of Gestational Diabetes
10. High Levels Of Iron in Pregnant Women Is A Risk To Gestational Diabetes
11. Cardiovascular Risk In Pregnant Women With Gestational Diabetes
12. Risk Reduction To Gestational Diabetes With Probiotics
13. Increased risk of gestational diabetes and high blood sugar levels (hyperglycemia) with short sleep duration
14. Risks With Under Performing Thyroid
15. Thyroid dysfunction or disorder (such as hyperthyroidism and hypothyroidism) was not associated with type 2 diabetes
16. Study To Prevent Gestational Diabetes Recurrence
17. Seasonal Variations In Gestational Diabetes Incidents
18. Increase in Risk Of Heart Disease With Higher Free Thyroxine (FT4) Thyroid Hormone




Site maps

Site map 1   Site map 2   Site map 3   Site map 4

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.

Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.